SXTP Nilai Total Aset Perusahaan 60 Degrees Pharma

This price trend visualization for the total assets of 60 Degrees Pharmaceuticals (SXTP), valued at 4.50, reflects the dynamics of the biotech business. The company's revenues are based on the sale of an anti-malarial drug, targeting government contracts and the tourism sector. Simultaneously, 60 Degrees Pharmaceuticals (SXTP) is implementing eco-friendly production and packaging methods, developing a pipeline of new antiviral drugs, and expanding clinical trials for tafenoquine.

Reverse calculation via ROA enables daily tracking of the total value of resources combining equity and liabilities, which eliminates the lag between quarterly reports and reveals the actual strength of the balance sheet. For 60 Degrees Pharmaceuticals (SXTP), these total assets reflect the capacity to scale the production of antimalarial drugs for government contracts and defense department needs, where any stagnation in the curve signals underinvestment risks.